Cite
HARVARD Citation
Harnett, J. et al. (n.d.). AB0399 Real-World Experience with Tofacitinib vs Adalimumab (ADA), Etanercept (ETN) and Abatacept (ABA) in Biologic-Experienced Patients with Rheumatoid Arthritis (RA): Data from A US Administrative Claims Database. Annals of the rheumatic diseases. pp. 1042-1043. [Online].